Breast cancer is the most common malignancy in individuals with a germline BRCA1/2 pathogenic variant, resulting in a lifetime risk ranging from 46% to 87% (Chen et al., 2006; Ford et al., 1994; Sankaran et al., 2006). This evidence concerns the gene BRCA1 and breast cancer.